Business

LifeMD Appoints Dr. Joan LaRovere to its Board of Directors

NEW YORK, Feb. 10, 2023 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ: LFMD), a leading direct-to-patient telehealth company, today announced the appointment of

articleLifemd, Inc.February 10, 20233/company/lifemd-inc/news/lifemd-appoints-dr-joan-larovere-to-its-board-of-directors
LifeMD Appoints Dr. Joan LaRovere to its Board of Directors

About this update from Lifemd, Inc.

[{"type":"text","content":"NEW YORK, Feb. 10, 2023 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ: LFMD), a leading direct-to-patient telehealth company, today announced the appointment of Dr. Joan LaRovere to its Board of Directors. With Dr. LaRovere’s appointment, LifeMD’s Board will comprise nine directors, seven of whom are independent. “We are pleased to welcome Dr. LaRovere to the LifeMD Board,” said Justin Schreiber, Chairman and Chief Executive Officer of LifeMD. “Dr. LaRovere’s leadership and clinical experience at two of the top hospitals in the world, combined with her deep background in healthcare data, analytics, machine learning, and artificial intelligence will be invaluable to LifeMD as we grow our business and pursue our mission to increase access to high quality and affordable virtual care.” Dr. LaRovere is Director of Innovation and Outcomes and an Attending Physician in Cardiovascular Critical Care at Boston Children’s Hospital, as well as an Assistant Professor of Pediatrics at Harvard Medical School since 2011. Before then, she was Chief of Pediatric Intensive Care and a member of the Children’s Services Management Committee at the Royal Brompton Hospital in London, where she was also a member of the faculty at Imperial College School of Medicine. Dr. LaRovere is also the Co-Founder and Vice-President of the Virtue Foundation, an NGO with Special Consultative Status to the United Nations that seeks to provide both short-term impactful and long-term sustainable development solutions to communities across the globe. She is also an advisor and Delta V board member of the Martin Trust Center for MIT Entrepreneurship and a Healthcare Operating Partner with iSelect Fund, a venture firm investing at the intersection of nutrition and healthcare. Dr. LaRovere holds a Bachelor of Arts in Visual and Environmental Studies from Harvard University, a Master of Science in Genetics from the University of St. Andrews in Scotland, a Doctorate in Medicine from Columbia University, and an MBA from the MIT Sloan School of Management. “I have always been deeply passionate about using technology to expand access to affordable healthcare. I believe that LifeMD has built a technology platform and affiliated medical group that will be a driving force in the next chapter of technology-enabled care in the United States and maybe beyond,” said Dr. Joan LaRovere. “I am...

More updates from Lifemd, Inc.